Open access · CC-BY
via OpenAlex
Bile Acids, Intestinal Barrier Dysfunction, and Related Diseases
Linsen Shi, Lihua Jin, Wendong Huang
Cells · 2023 · ▲ 116 citations
Abstract
The intestinal barrier is a precisely regulated semi-permeable physiological structure that absorbs nutrients and protects the internal environment from infiltration of pathological molecules and microorganisms. Bile acids are small molecules synthesized from cholesterol in the liver, secreted into the duodenum, and transformed to secondary or tertiary bile acids by the gut microbiota. Bile acids interact with bile acid receptors (BARs) or gut microbiota, which plays a key role in maintaining the homeostasis of the intestinal barrier. In this review, we summarize and discuss the recent studies on bile acid disorder associated with intestinal barrier dysfunction and related diseases. We focus on the roles of bile acids, BARs, and gut microbiota in triggering intestinal barrier dysfunction. Insights for the future prevention and treatment of intestinal barrier dysfunction and related diseases are provided.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3390/cells12141888
- Canonical
- link ↗
- Fetched
- 2026-08-02 MST
Cite this
APA
Shi, L., Jin, L., & Huang, W. (2023). Bile Acids, Intestinal Barrier Dysfunction, and Related Diseases. <em>Cells</em>. https://doi.org/10.3390/cells12141888
Vancouver
Shi L, Jin L, Huang W. Bile Acids, Intestinal Barrier Dysfunction, and Related Diseases. Cells. 2023. doi:10.3390/cells12141888.
BibTeX
@article{linsen2023BileAc,
title = {Bile Acids, Intestinal Barrier Dysfunction, and Related Diseases},
author = {Linsen Shi and Lihua Jin and Wendong Huang},
journal = {Cells},
year = {2023},
doi = {10.3390/cells12141888},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Diabetologia 2026
Citation only
Olfactory dysfunction in obesity and type 2 diabetes: mechanistic insights from preclinical models.
Biomedicines 2022
Open access · CC-BY
Implication of Intestinal Barrier Dysfunction in Gut Dysbiosis and Diseases
Frontiers in Cellular and Infection Microbiology 2022
Open access · CC-BY
The Gut Microbiota (Microbiome) in Cardiovascular Disease and Its Therapeutic Regulation
Molecular biomedicine 2026
Open access · OA
Gut microbiota and aging: current understanding and future perspectives.
Current Neuropharmacology 2016
Open access · OA
Inflammation in Depression and the Potential for Anti-Inflammatory Treatment
Frontiers in Nutrition 2022
Open access · CC-BY